Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B
Ching‐Lung Lai, Edward Gane, Yun‐Fan Liaw, Chao‐Wei Hsu et autres
BACKGROUND: Reducing hepatitis B virus (HBV) replication to minimal levels is emerging as a key therapeutic goal for chronic hepatitis B. METHODS: In this double-blind, phase 3 trial, 1370 patients with chronic hepatitis B were randomly assigned to receive 600 mg of …
cn, nz, tw, th, ca, de, us, gb, kr (code pays fourni par la source)